newsfilter
← Latest News
Business Wire·

FDA Grants Breakthrough Device Designation for Natera’s Multi-Cancer Early Detection Assay

Designation supports the development of a blood-based assay intended to screen for various cancers Natera, Inc. (NASDAQ:NTRA), a global leader in cell-free DNA and precision medicine, today announced that its